CRISPR/Cas9‐mediated deletion (4–13 bp) of the insulator CTCF binding site in the PDGFRA locus induced the expression of PDGFRA by 1.6‐fold in human glioblastoma cells (Flavahan et al, 2016). The gene discussed is CTCF; the disease is glioblastoma.